1.Yau T, Hsu C, Kim T-Y, Choo S-P, Kang Y-K, Hou M-M, Numata K, Yeo W, Chopra A, Ikeda M, Kuromatsu R, Moriguchi M, Chao Y, Zhao H, Anderson J, Cruz C, Kudo M. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis. J Hepatol. 2019;71(3):543–552. PMID: 31176752 Reference Link
1.Satoh T, Kang Y-K, Chao Y, Ryu M-H, Kato K, Chung H, Chen J-S, Muro K, Kang W, Yeh K-H, Yoshikawa T, Oh S, Bai L-Y, Tamura T, Lee K-W, Hamamoto Y, Kim J, Chin K, Oh D-Y, Minashi K, Cho J, Tsuda M, Tanimoto M, Chen L-T, Boku N. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer. 2020;23(1):143–153. PMCID: PMC6942596 Reference Link
1.Shrine N, Guyatt A, Erzurumluoglu M, Jackson V, Hobbs B, Melbourne C, Batini C, Fawcett K, Song K, Sakornsakolpat P, Li X, Boxall R, Reeve N, Obeidat M, Zhao J, Wielscher M, Weiss S, Kentistou K, Cook J, Sun B, Zhou J, Hui J, Karrasch S, Imboden M, Harris S, Marten J, Enroth S, Kerr S, Surakka I, Vitart V, Lehtimäki T, Allen R, Bakke P, Beaty T, Bleecker E, Bossé Y, Brandsma C-A, Chen Z, Crapo J, Danesh J, DeMeo D, Dudbridge F, Ewert R, Gieger C, Gulsvik A, Hansell A, Hao K, Hoffman J, Hokanson J, Homuth G, Joshi P, Joubert P, Langenberg C, Li X, Li L, Lin K, Lind L, Locantore N, Luan J, Mahajan A, Maranville J, Murray A, Nickle D, Packer R, Parker M, Paynton M, Porteous D, Prokopenko D, Qiao D, Rawal R, Runz H, Sayers I, Sin D, Smith B, Artigas M, Sparrow D, Tal-Singer R, Timmers P, Van den Berge M, Whittaker J, Woodruff P, Yerges-Armstrong L, Troyanskaya O, Raitakari O, Kähönen M, Polašek O, Gyllensten U, Rudan I, Deary I, Probst-Hensch N, Schulz H, James A, Wilson J, Stubbe B, Zeggini E, Jarvelin M-R, Wareham N, Silverman E, Hayward C, Morris A, Butterworth A, Scott R, Walters R, Meyers D, Cho M, Strachan D, Hall I, Tobin M, Wain L, Understanding Society Scientific Group. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat Genet. 2019;51(3):481–493. PMCID: PMC6397078 Reference Link
1.Park H-J, Lee K-W, Oh S, Yan R, Zhang J, Beach T, Adler C, Voronkov M, Braithwaite S, Stock J, Mouradian M. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease. J Neuropathol Exp Neurol. 2018;77(2):139–148. PMCID: PMC6251692 Reference Link
1.Chikina M, Gerald C, Li X, Ge Y, Pincas H, Nair V, Wong A, Krishnan A, Troyanskaya O, Raymond D, Saunders-Pullman R, Bressman S, Yue Z, Sealfon S. Low-variance RNAs identify Parkinson’s disease molecular signature in blood. Mov Disord. 2015;30(6):813–21. PMCID: PMC4439364 Reference Link
1.Snir S, vonHoldt B, Pellegrini M. A Statistical Framework to Identify Deviation from Time Linearity in Epigenetic Aging. PLoS Comput Biol. 2016;12(11):e1005183. PMCID: PMC5106012 Reference Link